What to Do If Your ADHD Medication Stops Working

The experience of a previously useful ADHD medication losing its effect is common and disorienting. The medication worked, the symptoms came back, and the question is what to do. This article covers the most frequent causes (some of which are not the medication at all), what a useful prescriber conversation looks like, and the structured options when a switch becomes the right move.

Is the medication actually the thing that has changed?

Before adjusting medication, the most useful question is whether the medication is what has changed, or whether the situation around the medication has changed. The most common things that make working medication feel less effective are not usually the medication itself.

Sleep

A reduction in sleep quantity or quality is the most common reason ADHD medication feels less effective. ADHD symptoms map closely onto symptoms of insufficient sleep: poor focus, irritability, low motivation, slow task initiation. A patient sleeping six hours instead of seven for several weeks will often interpret the resulting fog as "the medication is not working", when in fact the medication is doing the same work against a worsened backdrop.

Stress and demand

A new job, a difficult life event, family illness, financial pressure, or any sustained increase in demand changes the baseline. The medication has not lost effect; the load has increased. The same dose now feels insufficient because there is more to do.

Co-occurring mental health

Anxiety, depression, perimenopause, premenstrual worsening, ongoing trauma symptoms or undiagnosed sleep disorders all affect how ADHD presents and how medication feels. A new or worsening co-occurring condition is one of the most common reasons working medication feels less useful.

Hormonal change

Oestrogen affects dopamine and noradrenaline signalling. Menstrual cycle phase, perimenopause and menopause all shift how stimulants feel. Patients often describe a worsening of ADHD symptoms in the premenstrual phase and across perimenopause that is not really a change in the medication.

Substance use

Increased alcohol, cannabis, cocaine, or recreational stimulant use changes brain chemistry and interacts with prescribed medication. Reduced caffeine can also change the picture.

Inconsistent dosing

Missed doses, irregular timing, dosing on some days but not others, or splitting tablets without prescriber input can all make medication feel inconsistent. This is rarely the underlying issue but is worth ruling out.

The conversation with the prescriber is more useful if these have been considered first.

What about real tolerance?

True pharmacological tolerance to ADHD stimulants at therapeutic doses is debated in the research literature ^{[4, 5]}. Some short-term laboratory studies have shown reduced acute effects of stimulants over repeated dosing. Long-term clinical studies show that most patients maintain therapeutic effect over years of treatment at the same dose, suggesting tolerance is not the dominant clinical issue.

The patient experience of "the medication has stopped working" is therefore more often explained by changes in the surrounding picture than by pharmacological tolerance. That said, some patients do report that a dose increase is needed at some point, and prescribers do sometimes adjust upwards. The honest answer is that this is an area where individual variation is significant and prescriber judgement matters.

What a useful review looks like

A prescriber asked the "it has stopped working" question will usually want to cover ^{[1, 4]}:

• The timeline. When did it start to feel less useful? Gradual or sudden?
• Sleep, mood and stress changes over the same period
• Any change in dose timing, formulation, or missed doses
• Co-occurring conditions, including hormonal and mental health
• Substance use including alcohol and caffeine
• Other medication changes
• Blood pressure and heart rate, as a baseline for any adjustment

This is the same level of detail used in initial titration, applied to the current question. The aim is to work out which of the possibilities is most likely before changing the prescription.

The structured options when a change is needed

If the conversation lands on a real need to change something, the options under NICE NG87 include ^[1]:

Dose adjustment

An increase, within the licensed range and within the prescriber's clinical judgement, is the most straightforward first step. The starting point of the original titration may not be the right destination forever; some patients do need an adjustment after months or years.

Formulation change

A different brand of the same medication, or a different release profile, may suit a changed working day. A patient who was on a shorter-acting formulation when working from home may need a longer-acting one when working in the office, or vice versa.

Stimulant switch

A switch between the methylphenidate and amphetamine families is the most common structural change. Around a third of patients find one family suits them better than the other ^[4], and a switch sometimes produces a working option where the previously useful medication has stopped delivering.

Non-stimulant addition or switch

Where stimulants have stopped working at a tolerated dose, or where new side effects have emerged, atomoxetine or guanfacine may be considered.

Looking at the broader picture

Sometimes the right answer is not a medication change at all. Sleep treatment, addressing a co-occurring condition, structural changes at work, or non-pharmacological support may produce better outcomes than dose escalation. ADHD diagnosis is more than medication makes this case in more detail.

Practical points for the conversation

A few patient-side preparations make the review more useful:

• Document the change. When did you first notice? What changed in the weeks before? Are particular times of day affected?
• Note sleep specifically. Two weeks of sleep diary tells the prescriber more than a general description.
• Bring the other medications, supplements and over-the-counter products you take
• Bring an honest substance use picture, including caffeine and alcohol
• Be specific about what "stopped working" means. Loss of focus? Loss of emotional regulation? Loss of task initiation? Loss of one of these but not the others points in different directions.
• If you are female, bring the cycle picture. Hormonal context matters in this conversation.

What this means in practice

• "ADHD medication has stopped working" is common and is most often explained by changes around the medication rather than the medication itself.
• Sleep, stress, co-occurring mental health, hormonal change and substance use are the most frequent reasons.
• True tolerance to therapeutic-dose ADHD stimulants is debated in the literature and is not the dominant clinical explanation.
• A structured prescriber review can identify what has changed and which adjustment is most likely to help.
• The options include dose adjustment, formulation change, stimulant switch, non-stimulant change, or addressing factors outside the medication.

When to speak to a professional

Speak to your GP, your prescriber or NHS 111 if your ADHD medication is feeling significantly less effective, particularly if mood, sleep or daily function are deteriorating. Seek urgent help via 999 or A&E for any acute mental health crisis. NeuroFX offers private adult ADHD assessment and ADHD medication and prescribing with NeuroFX with structured review where the current medication has stopped delivering.

Sources

1. NICE. Attention deficit hyperactivity disorder: diagnosis and management. NG87. National Institute for Health and Care Excellence. https://www.nice.org.uk/guidance/ng87
2. British National Formulary. Methylphenidate hydrochloride. https://bnf.nice.org.uk/drugs/methylphenidate-hydrochloride/
3. British National Formulary. Lisdexamfetamine mesilate. https://bnf.nice.org.uk/drugs/lisdexamfetamine-mesilate/
4. Cortese S, Adamo N, Del Giovane C, et al. Comparative efficacy and tolerability of medications for attention-deficit/hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2018;5(9):727-738.
5. Faraone SV, Banaschewski T, Coghill D, et al. The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder. Neuroscience and Biobehavioral Reviews. 2021;128:789-818.